Sterile Injectable Drugs Market Size, Share, Growth Report 2030

Sterile Injectable Drugs Market

Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 02-Jan-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3690 Status : Published

Global sterile injectable drugs market expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024. The increasing preference for large molecule drugs over traditional drugs, rising incidences of chronic diseases fueling the global market.

Sterile Injectable Drugs Market

The report covers a forecast and an analysis of the sterile injectable drugs market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the sterile injectable drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the sterile injectable drugs market on a global level.

In order to give the users of this report a comprehensive view of the sterile injectable drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Sterile Injectable Drugs MarketRequest Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.

The study provides a decisive view of the sterile injectable drugs market by segmenting it based on type, drug class, indication, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Major players of the sterile injectable drugs market include GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co., Inc., Gilead Sciences Inc., Pfizer Inc., Novartis AG, and Nova Nordisk A/S, among others.

This report segments the global sterile injectable drugs market into:

Global Sterile Injectable Drugs Market: Type Analysis

  • Small Molecules
  • Large Molecules

Global Sterile Injectable Drugs Market: Drug Class Analysis

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccine
  • Immunoglobulin
  • Blood Factors
  • Others 

Global Sterile Injectable Drugs Market: Indication Analysis

  • Cardiology and Metabolic Disorders
  • Musculoskeletal Disorders
  • Neurology Disorders
  • Autoimmune
  • Oncology
  • Infectious Diseases
  • Others

Global Sterile Injectable Drugs Market: Distribution Channel Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce

Global Sterile Injectable Drugs Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed